Commercial (fluoro)quinolones ((F)Qs), ciprofloxacin (CIP), enrofloxacin (ENR), ofloxacin (OFL), oxolinic acid (OA) and flumequine (FLU) (3 mu M each), were degraded with solar-photo-Fenton in a compound parabolic concentrator photoreactor (total volume 5 L) in ultra-pure water at pH = 5.0, salty water at pH = 5.0, and simulated wastewater at pH = 5.0 and 7.5. Iron speciation (its hydrolysis and the complexation with (F)Qs 15 mu M and/or chlorides 0.5 M) was calculated at pH 5.0, observing, negligible formation of Fe(III)-chloride complexes, and that >99 % of the total (F)Qs are forming complexes stoichiometry 1:1 with Fe(III) (which also increases the percentage of Fe (OH)2+), being minoritarian the free antibiotic form. On the other hand, EEM-PARAFAC (fluorescence excitation -emission matrices-parallel factor analysis) was employed to simultaneously study the behaviour of: i) 4 structure -related groups corresponding to parent pollutants and slightly oxidised by-products, ENR-like (including CIP), OFL-like, OA-like, FLU-like; ii) intermediates still showing (F)Q characteristics (exhibiting analogous fluorescent finger-print to ENR-like one, but shifted to shorter wavelengths); iii) humic-like substances. The scores from the 4 PARAFAC components corresponding to the parent pollutants were plotted vs. accumulated energy, exhibiting slower decay than their individual removals (measured with HPLC-UV/vis) due to the contribution of the aforementioned by products to the overall fluorescence. Moreover, thiabendazole (TBZ) 3 mu M was added as fluorescence interference. The presence of (F)Qs greatly enhanced TBZ degradation due to (F)Q-Fe(III) complex formation, keeping iron active at pH = 5.0 for Fenton process. The EEM-PARAFAC model was able to recognise the former six components plus an additional one attributable to TBZ-like.
EEM-PARAFAC as a convenient methodology to study fluorescent emerging pollutants degradation: (fluoro)quinolones oxidation in different water matrices
Sciscenko I.
First
;
2022-01-01
Abstract
Commercial (fluoro)quinolones ((F)Qs), ciprofloxacin (CIP), enrofloxacin (ENR), ofloxacin (OFL), oxolinic acid (OA) and flumequine (FLU) (3 mu M each), were degraded with solar-photo-Fenton in a compound parabolic concentrator photoreactor (total volume 5 L) in ultra-pure water at pH = 5.0, salty water at pH = 5.0, and simulated wastewater at pH = 5.0 and 7.5. Iron speciation (its hydrolysis and the complexation with (F)Qs 15 mu M and/or chlorides 0.5 M) was calculated at pH 5.0, observing, negligible formation of Fe(III)-chloride complexes, and that >99 % of the total (F)Qs are forming complexes stoichiometry 1:1 with Fe(III) (which also increases the percentage of Fe (OH)2+), being minoritarian the free antibiotic form. On the other hand, EEM-PARAFAC (fluorescence excitation -emission matrices-parallel factor analysis) was employed to simultaneously study the behaviour of: i) 4 structure -related groups corresponding to parent pollutants and slightly oxidised by-products, ENR-like (including CIP), OFL-like, OA-like, FLU-like; ii) intermediates still showing (F)Q characteristics (exhibiting analogous fluorescent finger-print to ENR-like one, but shifted to shorter wavelengths); iii) humic-like substances. The scores from the 4 PARAFAC components corresponding to the parent pollutants were plotted vs. accumulated energy, exhibiting slower decay than their individual removals (measured with HPLC-UV/vis) due to the contribution of the aforementioned by products to the overall fluorescence. Moreover, thiabendazole (TBZ) 3 mu M was added as fluorescence interference. The presence of (F)Qs greatly enhanced TBZ degradation due to (F)Q-Fe(III) complex formation, keeping iron active at pH = 5.0 for Fenton process. The EEM-PARAFAC model was able to recognise the former six components plus an additional one attributable to TBZ-like.| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0048969722054377-main.pdf
Accesso aperto
Descrizione: Articolo OA
Tipo di file:
PDF EDITORIALE
Dimensione
2.94 MB
Formato
Adobe PDF
|
2.94 MB | Adobe PDF | Visualizza/Apri |
|
Revised manuscript with no changes marked.pdf
Accesso aperto
Descrizione: Articolo OA
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
1.52 MB
Formato
Adobe PDF
|
1.52 MB | Adobe PDF | Visualizza/Apri |
|
Supporting information.pdf
Accesso aperto
Descrizione: Supporting Information
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
425.52 kB
Formato
Adobe PDF
|
425.52 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



